| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jan―05 |
Generation of induced pluripotent stem cell line from a patient with long COVID |
David Wu, Amit Manhas, Chikage Noishiki, Dipti Tripathi, Lu Liu, Naima Turbes, et al. (+4) Dilip Thomas, Karim Sallam, Jason T. Lee, Nazish Sayed |
| 2 |
[GO] |
2023―Jan―05 |
Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis |
Martina Rabino, Erica Rurali, Chiara Zamboni, Davide Rovina, Sara Mallia, Matteo Cauteruccio, et al. (+4) Andrea Baggiano, Carlo Maria Giacari, Milena Bellin, Giulio Pompilio |
| 3 |
[GO] |
2021―Jul―17 |
COVID-19 |
Xiajun Li, Albert Jiarui Li, Bin Du |
| 4 |
[GO] |
2021―Jun―20 |
Non-permissive SARS-CoV-2 infection in human neurospheres |
Carolina da S.G. Pedrosa, Livia Goto-Silva, Jairo R. Temerozo, Leticia R.Q. Souza, Gabriela Vitória, Isis M. Ornelas, et al. (+22) Karina Karmirian, Mayara A. Mendes, Ismael C. Gomes, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Vinicius Cardoso Soares, Suelen da Silva Gomes Dias, José Alexandre Salerno, Teresa Puig-Pijuan, Julia T. Oliveira, Luiz G.H.S. Aragão, Thayana C.Q. Torquato, Carla Veríssimo, Diogo Biagi, Estela M. Cruvinel, Rafael Dariolli, Daniel R. Furtado, Helena L. Borges, Patrícia T. Bozza, Stevens Rehen, Thiago Moreno L. Souza, Marília Zaluar P. Guimarães |
| 5 |
[GO] |
2021―Feb―21 |
Human Pluripotent Stem Cell-based Organoids and Cell Platforms for Modelling SARS-CoV-2 Infection and Drug Discovery |
Alice Maria Giani, Shuibing Chen |
| 6 |
[GO] |
2021―Feb―11 |
Medical progress: Stem cells as a new therapeutic strategy for COVID-19 |
Claudia Musial, Magdalena Gorska-Ponikowska |
| 7 |
[GO] |
2021―Feb―06 |
Effect of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) on Reproductive System |
Nengzhuang Wang, Lina Qin, Long Ma, Hongli Yan |
| 8 |
[GO] |
2021―Feb―03 |
Structural insights into SARS-CoV-2 infection and therapeutics development |
Gangyu Sun, Lulu Xue, Qingjing He, Yue Zhao, Wenqing Xu, Zhizhi Wang |
| 9 |
[GO] |
2021―Jan―27 |
Eyes on Coronavirus |
Yan-Ping Li, Ya Ma, Ningli Wang, Zi-Bing Jin |
| 10 |
[GO] |
2021―Jan―26 |
Generation of WAe001-A-58 human embryonic stem cell line with inducible expression of the SARS-CoV-2 nucleocapsid protein |
Feima Wu, Yan Chen, Kai You, Shenglin Tan, Yingying Xu, Pei-Hui Wang, et al. (+2) Shiming Liu, Yin-xiong Li |
| 11 |
[GO] |
2021―Jan―14 |
The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries |
Ni Li, Linwen Zhu, Lebo Sun, Guofeng Shao |
| 12 |
[GO] |
2020―Dez―17 |
Sex-dependent immune response and lethality of COVID-19 |
Albert Jiarui Li, Xiajun Li |
| 13 |
[GO] |
2020―Dez―16 |
Neutralizing antibodies targeting SARS-CoV-2 spike protein |
Shi Xiaojie, Li Yu, Yan lei, Yang Guang, Qiang Min |
| 14 |
[GO] |
2020―Dez―09 |
Furin cleavage sites naturally occur in coronaviruses |
Yiran Wu, Suwen Zhao |
| 15 |
[GO] |
2020―Okt―24 |
A safety consideration of mesenchymal stem cell therapy on COVID-19 |
Yajun Cao, Hongyan Wu, Wanli Zhai, Ying Wang, Mengdi Li, Meng Li, et al. (+9) Liu Yang, Ye Tian, Yunhao Song, Jun Li, Yinyin Wang, Qiang Ding, Linqi Zhang, Ming Cai, Zhijie Chang |
| 16 |
[GO] |
2020―Jun―01 |
SARS-CoV-2 infection and stem cells: interaction and intervention |
Fenggang Yu, Rufu Jia, Yongyong Tang, Jin Liu, Benjie Wei |
|
